GURUFOCUS.COM » STOCK LIST » Industrials » Waste Management » Stericycle Inc (NAS:SRCL) » Definitions » Cash Flow from Financing

Stericycle (Stericycle) Cash Flow from Financing : $-100 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Stericycle Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Stericycle paid $6 Mil more to buy back shares than it received from issuing new shares. It received $116 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0 Mil from paying cash dividends to shareholders. It received $0 Mil on other financial activities. In all, Stericycle earned $109 Mil on financial activities for the three months ended in Mar. 2024.


Stericycle Cash Flow from Financing Historical Data

The historical data trend for Stericycle's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stericycle Cash Flow from Financing Chart

Stericycle Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -141.60 -892.50 -207.90 -111.00 -220.40

Stericycle Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.60 -196.30 2.70 -15.20 109.30

Stericycle Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Stericycle's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Stericycle's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-100 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stericycle  (NAS:SRCL) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Stericycle's issuance of stock for the three months ended in Mar. 2024 was $0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Stericycle's repurchase of stock for the three months ended in Mar. 2024 was $-6 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Stericycle's net issuance of debt for the three months ended in Mar. 2024 was $116 Mil. Stericycle received $116 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Stericycle's net issuance of preferred for the three months ended in Mar. 2024 was $0 Mil. Stericycle paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Stericycle's cash flow for dividends for the three months ended in Mar. 2024 was $0 Mil. Stericycle received $0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Stericycle's other financing for the three months ended in Mar. 2024 was $0 Mil. Stericycle received $0 Mil on other financial activities.


Stericycle Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Stericycle's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Stericycle (Stericycle) Business Description

Traded in Other Exchanges
Address
2355 Waukegan Road, Bannockburn, IL, USA, 60015
Stericycle is the largest provider of medical waste disposal and data destruction (primarily paper shredding) services in the United States. Its next closest national competitor in the medical waste disposal space is Sharps Compliance, which generated $76 million of sales in fiscal 2021 before its 2022 acquisition (about 4% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business (Shred-It) is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle has a global presence, with about 20% of its revenue earned outside North America.
Executives
Joseph Anthony Reuter officer: EVP & Chief People Officer 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Victoria L Dolan director C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK NY 10022
Naren K Gursahaney director 1501 YAMATO ROAD, BOCA RATON FL 33431
White Stephen Cory officer: EVP C&RS 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Daniel Ginnetti officer: Chief Financial Officer 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
David W. Stahl officer: EVP and CIO 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
James L Welch director 5550 SW MACADAM AVENUE, SUITE 200, PORTLAND OR 97239
James J Martell director 314 RINGLING POINT DRIVE, SARASOTA FL 34234
Janet Zelenka officer: EVP, Chief Financial Officer 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Dominic Culotta officer: EVP Engineering 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Mark C Miller officer: CEO C/O STERICYCLE INC., 28161 N KEITH DRIVE, LAKE FOREST IL 60045
Stephen C Hooley director 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
Hackney Jesse Joel Jr director 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015
William J. Seward officer: EVP, Chief Commercial Officer 28161 N. KEITH DRIVE, LAKE FOREST IL 60045
Richard Michael Moore officer: EVP North America Operations 2355 WAUKEGAN ROAD, BANNOCKBURN IL 60015

Stericycle (Stericycle) Headlines